Christophe Hélary

Dr. Christophe Hélary


Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2010 in Biomaterials
Verified
Journal Article
Closed access
CHChristophe Hélary
Christophe Hélary
IBIsabelle Bataille
Isabelle Bataille
AAAicha Abed
Aicha Abed
CICorinne Illoul
Corinne Illoul
AAAnnie Anglo
Annie Anglo
MGMarie Madeleine Giraud-Guille
Marie Madeleine Giraud-Guille

8 May 2014 in Journal of Materials Chemistry B
Verified
Journal Article
Closed access
PDF file
GAGisela Solange Alvarez
Gisela Solange Alvarez
CHChristophe Hélary
Christophe Hélary
AMAndrea Mathilde Mebert
Andrea Mathilde Mebert
XWXiaolin Wang
Xiaolin Wang
Thibaud CoradinThibaud Coradin
Thibaud Coradin
Martin DesimoneMartin Desimone
Martin Desimone
Silica–collagen type I nanocomposite hydrogels are evaluated as medicated dressings to prevent infection in chronic wounds. Two antibiotics, gentamicin and rifamycin, are encapsulated in a single step within plain silica nanoparticles. Their antimicrobial efficiency against Pseudomonas aeruginosa and Staphylococcus aureus is assessed. Gentamycin-loaded 500 nm particles can be immobilized at high silica dose in concentrated collagen hydrogels without modifying their fibrillar structure or impacting on their rheological behavior and increases their proteolytic stability. Gentamicin release from the nanocomposites is sustained over 7 days, offering an unparalleled prolonged antibacterial activity. Particle immobilization also decreases their cytotoxicity towards surface-seeded fibroblast cells. Rifamycin-loaded 100 nm particles significantly alter the collagen hydrogel structure at high silica doses. The thus-obtained nanocomposites show no antibacterial efficiency, due to strong adsorption of rifamycin on collagen fibers. The complex interplay of interactions between drugs, silica and collagen is a key factor regulating the properties of these composite hydrogels as antibiotic-delivering biological dressings and must be taken into account for future extension to other wound healing agents.

15 August 2019 in PLOS ONE
Verified
Journal Article
Open access
PDF file
MMMangesh Morey
Mangesh Morey
POPeadar O'GAora
Peadar O'GAora
Abhay PanditAbhay Pandit
Abhay Pandit
CHChristophe Hélary
Christophe Hélary
Diabetic foot ulcers (DFUs) are characterized by a chronic inflammation state which prevents cutaneous wound healing, and DFUs eventually lead to infection and leg amputation. Macrophages located in DFUs are locked in an pro-inflammatory phenotype. In this study, the effect of hyperglycemia and hypoxia on the macrophage phenotype was analyzed. For this purpose, a microarray was performed to study the gene expression profile of macrophages cultivated in a high glucose concentration. Hyperglycemia upregulated the expression of pro-inflammatory cytokines such as TNF-α, IL-1, IL-6, chemokines and downregulated the expression of two receptors involved in phagocytosis (CD 36 and Class B scavenger type I receptors). In addition, eleven anti-apoptotic factors were upregulated whereas three pro-apoptotic genes were downregulated. Subsequently, the contribution of hypoxia and hyperglycemia to chronic inflammation and their potential synergistic effect was evaluated on activated THP-1 derived macrophages. A long term post activation effect (17 hours) was only observed on the upregulation of pro-inflammatory cytokines when hypoxia was combined with a high glucose concentration. In contrast, hyperglycemia and hypoxia did not have any effect on wound healing molecules such as TGF-β1. Taken together, the results show that hyperglycemia acts in synergy with hypoxia to maintain a chronic inflammation state in macrophages.

1 October 2010 in Acta Biomaterialia
Verified
Journal Article
Closed access
Martin DesimoneMartin Desimone
Martin Desimone
CHChristophe Hélary
Christophe Hélary
Ivo Boudewijn RietveldIvo Boudewijn Rietveld
Ivo Boudewijn Rietveld
IBIsabelle Bataille
Isabelle Bataille
GMGervaise Mosser
Gervaise Mosser
Thibaud CoradinThibaud Coradin
Thibaud Coradin

15 June 2006 in Journal of Materials Chemistry
Verified
Journal Article
Closed access
PDF file
JAJoachim Allouche
Joachim Allouche
BMBoissière Michel
Boissière Michel
CHChristophe Hélary
Christophe Hélary
JLJacques Livage
Jacques Livage
Thibaud CoradinThibaud Coradin
Thibaud Coradin
Hybrid nanoparticles have great potential for biotechnological and biomedical applications. It was recently proposed that biopolymer/silica nanomaterials could be easily obtained by adapting traditional routes used in pharmaceutical science to design polymer nanoparticles. In this paper, we demonstrate that core–shell gelatine/silica nanoparticles can be obtained using a nano-emulsion route, taking advantage of the thermal gelation properties of the biopolymer and of its strong “biomimetic” affinity for silicates. The formation of the silica coating could be ascertained by SEM, TEM, EDAX, FTIR and DLS/zeta potential measurements. Silica coating was also performed on microparticles, allowing us to investigate in more detail the mechanism of silica deposition on the gelatine surface, which bears some relevance for the understanding of biosilicification processes. Finally, the possible internalization and intracellular degradation of these hybrid nanoparticles by fibroblast cells was demonstrated. A comparison with previously described silica/alginate nanoparticles is provided in the context of drug-delivery system design.

16 December 2014 in Biomaterials Science
Verified
Journal Article
Closed access
PDF file
CHChristophe Hélary
Christophe Hélary
AAAicha Abed
Aicha Abed
GMGervaise Mosser
Gervaise Mosser
LLLiliane Louedec
Liliane Louedec
Didier LetourneurDidier Letourneur
Didier Letourneur
AMAnne Meddahi-Pellé
Anne Meddahi-Pellé
Cutaneous chronic wounds are characterized by an impaired wound healing which may lead to infection and amputation. When current treatments are not effective enough, the application of wound dressings is required. To date, no ideal biomaterial is available. In this study, highly dense collagen matrices have been evaluated as novel medicated wound dressings for the treatment of chronic wounds. For this purpose, the structure, mechanical properties, swelling ability and in vivo stability of matrices concentrated from 5 to 40 mg mL−1 were tested. The matrix stiffness increased with the collagen concentration and was associated with the fibril density and thickness. Increased collagen concentration also enhanced the material resistance against accelerated digestion by collagenase. After subcutaneous implantation in rats, dense collagen matrices exhibited high stability without any degradation after 15 days. The absence of macrophages and neutrophils evidenced their biocompatibility. Subsequently, dense matrices at 40 mg mL−1 were evaluated as drug delivery system for ampicillin release. More concentrated matrices exhibited the best swelling abilities and could absorb 20 times their dry weight in water, allowing for an efficient antibiotic loading from their dried form. They released efficient doses of antibiotics that inhibited the bacterial growth of Staphylococcus Aureus over 3 days. In parallel, they show no cytotoxicity towards human fibroblasts. These results show that dense collagen matrices are promising materials to develop medicated wound dressings for the treatment of chronic wounds.